Linda R Gooden
CIK 1382867 · Executive Vice President · last filed 2025-10-06
Linda R Gooden is an Executive Vice President who has filed 77 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for BHG, was dated Oct 6, 2025. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.4M across reported positions. 31 SEC filings were submitted jointly with LOCKHEED MARTIN CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LMT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6801 ROCKLEDGE DRIVE
BETHESDA, MD 20817
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NeueHealth, Inc. (BHG) Delisted | Director | 0 | $16.35 | $0 | $0 | 3 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | Director | 16,443 | $6.75 | $111.0K | $0 | 2 | 2025-05-15 |
| GM | Director | — | $80.54 | — | $0 | 6 | 2025-01-03 |
| HD | Director | 1,500 | $318.50 | $477.8K | $290.5K | 11 | 2023-05-22 |
| General Motors Co (GM.WS.B) Delisted | Director | — | — | — | $0 | 4 | 2019-01-03 |
| ADP | Director | 34,145 | $293.11 | $10.01M | -$589.4K | 13 | 2018-11-07 |
| WGL HOLDINGS INC (WGL) Delisted | Director | 9,005 | — | — | $0 | 6 | 2018-01-04 |
| General Motors Co (GM.WS.C) Delisted | Director | 1,000 | — | — | $35.4K | 1 | 2015-05-01 |
| LMT | Executive Vice President | 22,404 | $622.99 | $13.96M | -$3.81M | 30 | 2013-03-12 |
Recent Filings
77 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-06 | NeueHealth, Inc. (BHG) Delisted | Disp (D) | −16,443 | $0 | EDGAR |
| 2025-05-15 | NeueHealth, Inc. (NEUE) Delisted | Exer (M) | +10,500 | $0 | EDGAR |
| 2025-01-03 | GM | Grant (A) | — | $0 | EDGAR |
| 2024-05-14 | NeueHealth, Inc. (NEUE) Delisted | Mixed | +4,755 | $0 | EDGAR |
| 2024-01-03 | GM | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | HD | Grant (A) | — | $0 | EDGAR |
| 2023-05-16 | NeueHealth, Inc. (BHG) Delisted | Mixed | +95,109 | $0 | EDGAR |
| 2023-01-04 | GM | Grant (A) | — | $0 | EDGAR |
| 2022-05-23 | HD | Grant (A) | — | $0 | EDGAR |
| 2022-05-17 | NeueHealth, Inc. (BHG) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.